Last reviewed · How we verify
Manzanilla Sophia®
At a glance
| Generic name | Manzanilla Sophia® |
|---|---|
| Sponsor | Laboratorios Sophia S.A de C.V. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes (PHASE4)
- Study of Non-inferiority Between Manzanilla Sophia® and Meticel Ofteno® 0.5% for Providing a Soothing Sensation to the Eyes. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manzanilla Sophia® CI brief — competitive landscape report
- Manzanilla Sophia® updates RSS · CI watch RSS
- Laboratorios Sophia S.A de C.V. portfolio CI